
BD (Becton, Dickinson and Company)
BD (Becton, Dickinson and Company)
Content by BD (Becton, Dickinson and Company)
|1 min read
Expanding Access and Enabling Risk-Based Cervical Cancer Screening
How self-collection* and extended genotyping may help improve screening rates and support risk stratificationSponsored by
|2 min read
BD Announces CE Mark of Portable, Rapid Point-of-Care Antigen Test to Detect SARS-CoV-2 in 15 Minutes
SARS-CoV-2 Assay for BD Veritor™ Plus System to be available in Europe by end of OctoberPage 1 of 1





